Zynerba Pharmaceuticals Stock Technical Analysis

ZYNEDelisted Stock  USD 1.30  0.04  3.17%   
As of the 19th of April, Zynerba Pharmaceuticals maintains the Mean Deviation of 8.95, downside deviation of 2.92, and Market Risk Adjusted Performance of 2.29. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zynerba Pharmaceuticals, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Zynerba Pharmaceuticals, which can be compared to its peers. Please check out Zynerba Pharmaceuticals information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Zynerba Pharmaceuticals is priced fairly, providing market reflects its latest price of 1.3 per share. Given that Zynerba Pharmaceuticals is a hitting penny stock territory we urge to closely look at its total risk alpha.

Zynerba Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zynerba, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Zynerba
  
Zynerba Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Zynerba Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Zynerba Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Zynerba Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Zynerba Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Zynerba Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Zynerba Pharmaceuticals. You can use it to identify possible trend reversals for Zynerba Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Zynerba Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Zynerba Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Zynerba Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of   0.02  , which means Zynerba Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 14.67, which is the sum of squared deviations for the predicted Zynerba Pharmaceuticals price change compared to its average price change.

About Zynerba Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zynerba Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zynerba Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zynerba Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Zynerba Pharmaceuticals. By analyzing Zynerba Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zynerba Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zynerba Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Zynerba Pharmaceuticals April 19, 2024 Technical Indicators

Most technical analysis of Zynerba help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zynerba from various momentum indicators to cycle indicators. When you analyze Zynerba charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Zynerba Stock

If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bonds Directory
Find actively traded corporate debentures issued by US companies
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities